Delivery Order SPE2DB22D1052-SPE2DB25FV0DM
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a ceiling value of $19,963.95. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 26, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count) with a ceiling value of $26,581.56. This firm fixed-price delivery order, which carries an ultimate completion date of August 11, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- The Defense Logistics Agency awarded a $34.3K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1B and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,899.43 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on August 11, 2025, with ultimate completion by August 12, 2025. This firm fixed price delivery order carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Concerta ER 18 mg tablets (100 count) with a contract value of $3,513.92. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025. The award was made through open competition with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Concerta ER 18 mg tablets (100 count) with a ceiling value of $11,629.84. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 27, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $2,444.15. This competitively awarded, firm fixed-price delivery order is not set aside for any particular business category and carries an ultimate completion date of August 25, 2025. The contract is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Concerta ER 18 mg tablets (100 count) valued at $18,688.60 under a firm fixed price contract. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100-count units) valued at $8,934.20 under a firm fixed-price contract. This non-set-aside award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FV0DMDelivery Order
The Defense Logistics Agency awarded a $8,328.42 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Concerta ER 18 mg tablets (100-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, with a completion date of September 29, 2025. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's medical supply chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems. The company's DLA contract vehicle demonstrates its capability to deliver diverse medications across multiple therapeutic domains to support Defense Health Agency and other federal customers worldwide. This delivery order for the methylphenidate extended-release medication reflects the company's ongoing role in fulfilling federal pharmaceutical procurement requirements through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/26/25 |